Medical imaging scans that create detailed images of the body's internal structures are widely used in medicine. Doctors need ...

Raipur, installed an automated radio synthesizer and Gallium generator in its nuclear medicine department. This facility ...

Topline data from Clarity's diagnostic Phase II trial, DISCO, confirms that 64 Cu-SARTATE is safe and highly effective ...

AIIMS Raipur has enhanced its nuclear medicine department with an automated radio synthesizer and Gallium generator, becoming ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix", "the Company") today announces that its prostate cancer PET[1] ...

The Institute for Drug Research, The School of Pharmacy, The Faculty of Medicine, Campus Ein Karem, The Hebrew University, Jerusalem 9112001, Israel ...

(UroToday.com) The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL between May 30 th and June 3 rd, 2025, was host to a prostate, testicular, and penile cancers ...

The primary end point is rPFS by PSMA PET-CT as assessed by blinded independent central review (BICR). Secondary end points include metastasis-free survival by conventional imaging by BIRC, time to ...

Minimal residual disease-negativity after treatment in DLBCL strongly correlates with remission and overall survival. However ...

This review explores the role of PET in imaging immune activation ... with the immune system being both a natural barrier to cancer progression and a therapeutic target. 18 F-FDG PET/CT has become an ...

GE HealthCare (Nasdaq: GEHC) today announced that the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ® ) for ...

The pivotal AMPLIFY trial aims to support FDA approval of ⁶⁴Cu-SAR-bisPSMA as a best-in-class imaging tool in prostate cancer ...